Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle …
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases |
Nature Reviews Gastroenterology & Hepatology Skip to main content Thank you for visiting …
Nature Reviews Gastroenterology & Hepatology Skip to main content Thank you for visiting …
Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases
Background Nonalcoholic fatty liver disease (NAFLD) is prevalent worldwide and is
associated with the risk of many extrahepatic diseases. However, whether NAFLD is a risk …
associated with the risk of many extrahepatic diseases. However, whether NAFLD is a risk …
Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care
JP Nogueira, K Cusi - Diabetes Spectrum, 2024 - Am Diabetes Assoc
Insulin resistance is implicated in both the pathogenesis of nonalcoholic fatty liver disease
(NAFLD) and its progression from steatosis to steatohepatitis, cirrhosis, and even …
(NAFLD) and its progression from steatosis to steatohepatitis, cirrhosis, and even …
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study
Z Guo, T Zhang, Z Yun, Q Jin, X Cao, D Kong… - Frontiers in …, 2023 - frontiersin.org
Background: Non-alcoholic fatty liver disease (NAFLD) is a liver disease associated with
obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and metabolic syndrome. The …
obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and metabolic syndrome. The …
NAFLD in cardiovascular diseases: A contributor or comorbidity?
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular diseases are both highly
prevalent conditions around the world, and emerging data have shown an association …
prevalent conditions around the world, and emerging data have shown an association …
[HTML][HTML] Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer
Background & Aims The mechanisms underlying the association of steatotic liver disease
with cardiovascular and cancer outcomes are poorly understood. We aimed to use MRI …
with cardiovascular and cancer outcomes are poorly understood. We aimed to use MRI …
Non‐alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: a Mendelian randomization study
Aim To investigate the potential causal relationship between non‐alcoholic fatty liver
disease (NAFLD) and complications in type 1 diabetes (T1D) and type 2 diabetes (T2D) …
disease (NAFLD) and complications in type 1 diabetes (T1D) and type 2 diabetes (T2D) …
Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study
H Gellert‐Kristensen, A Tybjærg‐Hansen… - Liver …, 2023 - Wiley Online Library
Abstract Background & Aims Fatty liver disease has been associated with higher all‐cause
as well as liver‐related, ischemic heart disease (IHD)‐related and extrahepatic cancer …
as well as liver‐related, ischemic heart disease (IHD)‐related and extrahepatic cancer …
NAFLD: An emerging causal factor for cardiovascular disease
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide that poses a significant threat to human health. Cardiovascular disease (CVD) is …
worldwide that poses a significant threat to human health. Cardiovascular disease (CVD) is …